| Financial Year |
March 31 2023 |
| Monetary Funds |
4,851,305,430.62 |
| Held-for-trading Financial Assets |
497,227,437.00 |
| Notes Receivable |
1,040,588,736.14 |
| Accounts Receivable |
2,777,982,286.73 |
| Advances to Suppliers |
762,908,970.39 |
| Other Receivables |
589,919,813.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
11,350,292.88 |
| Inventories |
15,329,359,659.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,474,184.41 |
| Other Current Assets |
346,123,087.50 |
| Total Current Assets |
28,868,920,597.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
29,676,291.28 |
| Long-term Equity Investment |
282,156,689.69 |
| Investment Properties |
84,462,843.80 |
| Fixed Assetes |
4,379,531,856.43 |
| Under-construction Projects |
1,507,133,529.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
587,190,819.29 |
| R&D expenses |
-- |
| Goodwill |
31,749,056.28 |
| Long-Term Deferred and Prepaid Expenses |
488,324,376.63 |
| Deferred Income Tax Assets |
718,779,438.79 |
| Other Non-Current Assets |
218,596,726.32 |
| Sub-Total of Non-Current Assets |
9,603,993,129.55 |
| Total Assets |
38,472,913,726.88 |
| Short-Term Loans |
2,046,347,477.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,122,623,267.44 |
| Accounts Payable |
2,550,749,802.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
149,590,057.37 |
| Taxes Payable |
127,593,074.02 |
| Interest Payable |
-- |
| Dividend Payable |
48,119,602.94 |
| Other payables |
450,527,959.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,836,339,358.25 |
| Other Current Liabilities |
944,180,061.39 |
| Sub-Total of Current Liabilities |
9,496,866,453.92 |
| Long-term Loans |
1,281,413,877.50 |
| Bonds Payable |
1,216,965,698.63 |
| Long-Term Accounts Payable |
25,212,439.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
74,611,347.02 |
| Other Non-Current Liabilities |
1,666,270.59 |
| Sub-Total of Non-Current Liabilities |
2,972,333,262.91 |
| Total Liabilities |
12,469,199,716.83 |
| Paid-In Capital(Or Share Stock) |
3,615,065,842.00 |
| Capital Surplus |
133,440,707.51 |
| Surplus Reserve |
2,348,463,401.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
14,420,543,725.94 |
| Minority Stockholder's Interest |
5,242,487,030.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,761,226,979.82 |
| Owner's Equity（Stockholder's Equity） |
26,003,714,010.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,472,913,726.88 |
